European Archives - Page 1132 of 1159 - European Medical Journal

EMJ

The Role of GPs

Recently, I spoke to a group about the role of the General Practitioner (GP) in the community, about the complexity of the role, and about its challenges…

EMJ

The Oncotype DX® Test and Precision Oncology: New Data Presented at ESMO Further Demonstrate Genomic Health’s Successful Approach to Understanding Tumour Biology

GENEVA, Switzerland, [September 29, 2014] — In line with this year’s theme for the annual European Society for Medical Oncology (ESMO) Congress…

EMJ

The EMJ Cow Adventures: ERS 2014 Edition

This year, our EMJ team travelled to Munich to attend and review the 24th Annual Congress of the European Respiratory Society (ERS).

EMJ

ESMO Announces 15 New Designated Centres of Integrated Oncology and Palliative Care

Lugano, 19 September 2014 – Gaps in palliative care for cancer patients are revealed in new research to be presented later at the ESMO 2014 Congress…

EMJ

ACCA Congress: Ensuring a Rapid Response to Cardiac Emergencies

Monday 16 September 2014 Sophia Antipolis, France – Acute cardiovascular care is the specialty of cardiology dealing with acute problems in need of…

Review: Genetics of Urolithiasis

Urolithiasis constitutes a worldwide health problem with a frequency of up to 15% in the general population.

Review: Evolution of Minimally Invasive Radical Prostatectomy – A Continuous Development

During the last 15 years, minimally invasive surgery has been introduced gradually in surgical treatment for prostate cancer (CaP).

EMJ

Stigma is a Side-Effect of HIV Prevention Medicine

100,000 people are living with HIV within the UK, and one-quarter of these are undiagnosed. This is not only within the capital; latest research suggests…

EMJ Hepatology 1[Suppl 1] 2014

The main objective of chronic hepatitis C virus (HCV) management is to provide high viral eradication rates with acceptable toxicity.

EMJ

European Commission Grants Marketing Authorisation for Gilead’s Zydelig® (Idelalisib) for the Treatment of Chronic Lymphocytic Leukaemia and Follicular Lymphoma

Foster City, CA, 19 September 2014 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission has granted marketing…